CFS Investment Advisory Services LLC acquired a new stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 31,259 shares of the financial services provider's stock, valued at approximately $3,495,000.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Spinnaker Trust boosted its stake in shares of Aflac by 2.7% during the 3rd quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider's stock valued at $405,000 after purchasing an additional 95 shares in the last quarter. Secure Asset Management LLC lifted its stake in shares of Aflac by 1.0% in the third quarter. Secure Asset Management LLC now owns 9,783 shares of the financial services provider's stock worth $1,094,000 after buying an additional 96 shares in the last quarter. Ascent Group LLC lifted its stake in shares of Aflac by 0.6% in the second quarter. Ascent Group LLC now owns 17,231 shares of the financial services provider's stock worth $1,539,000 after buying an additional 99 shares in the last quarter. Ieq Capital LLC raised its holdings in shares of Aflac by 0.5% during the second quarter. Ieq Capital LLC now owns 21,775 shares of the financial services provider's stock valued at $1,945,000 after purchasing an additional 101 shares during the last quarter. Finally, New Century Financial Group LLC raised its holdings in shares of Aflac by 2.5% during the third quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider's stock valued at $469,000 after purchasing an additional 101 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company's stock.
Aflac Price Performance
Shares of NYSE AFL traded up $0.66 during trading on Friday, hitting $112.39. 1,606,623 shares of the company were exchanged, compared to its average volume of 2,214,558. The company has a market cap of $62.44 billion, a price-to-earnings ratio of 16.88, a PEG ratio of 2.14 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. Aflac Incorporated has a 1 year low of $75.07 and a 1 year high of $115.50. The firm's fifty day moving average price is $110.66 and its 200 day moving average price is $100.24.
Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business had revenue of $2.95 billion during the quarter, compared to the consensus estimate of $4.30 billion. During the same quarter in the previous year, the company posted $1.84 EPS. The business's revenue was down 40.4% on a year-over-year basis. On average, sell-side analysts expect that Aflac Incorporated will post 7.22 earnings per share for the current fiscal year.
Aflac Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.78%. The ex-dividend date is Wednesday, November 20th. Aflac's payout ratio is 30.12%.
Wall Street Analysts Forecast Growth
A number of brokerages have commented on AFL. Wells Fargo & Company upped their target price on shares of Aflac from $106.00 to $107.00 and gave the company an "equal weight" rating in a report on Tuesday, November 5th. Morgan Stanley increased their price objective on shares of Aflac from $91.00 to $98.00 and gave the company an "equal weight" rating in a research report on Monday, August 19th. Barclays initiated coverage on shares of Aflac in a research note on Wednesday, September 4th. They issued an "underweight" rating and a $96.00 target price on the stock. TD Cowen assumed coverage on shares of Aflac in a research note on Wednesday, October 9th. They issued a "hold" rating and a $102.00 target price on the stock. Finally, Piper Sandler raised their price target on shares of Aflac from $114.00 to $122.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 2nd. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Aflac currently has an average rating of "Hold" and a consensus target price of $97.93.
View Our Latest Stock Report on AFL
Aflac Company Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Recommended Stories
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.